Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY1A | P0DUB6 | 4/20 | 1.00 |
| ▸ | PIM1 | P11309 | 3/20 | 1.00 |
| ▸ | CD38 | P28907 | 3/20 | 1.00 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 9/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.72 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.72 |
| ▸ | MAPT | P10636 | 7/20 | 0.72 |
| ▸ | RECQL | P46063 | 6/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.72 |
| ▸ | TP53 | P04637 | 5/20 | 0.72 |
| ▸ | SLCO2B1 | O94956 | 5/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | HPGD | P15428 | 5/20 | 0.72 |
| ▸ | APP | P05067 | 5/20 | 0.72 |
| ▸ | XDH | P47989 | 5/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetagetin SCHEMBL29690479 | 1.00 | AMY1A (1.00) | AMY1APIM1CD38MAPK8MEN1 | |
| Quercetagetin SCHEMBL29608135 | 1.00 | AMY1A (1.00) | AMY1APIM1CD38MAPK8MEN1 | |
| Quercetagetin SCHEMBL7647221 | 0.94 | AMY1A (0.89) | AMY1APIM1CD38MAPK8MEN1 | |
| Quercetagetin SCHEMBL28164757 | 0.93 | AMY1A (0.87) | AMY1APIM1CD38MAPK8MEN1 | |
| SCHEMBL31022147 | 0.90 | AMY1A (0.81) | AMY1APIM1CD38MAPK8MEN1 | |
| SCHEMBL4879748 | 0.88 | AMY1A (0.78) | AMY1APIM1CD38MAPK8MEN1 | |
| SCHEMBL25926916 | 0.87 | MAPK8 (1.00) | AMY1APIM1CD38MAPK8MEN1 | |
| SCHEMBL14259668 | 0.87 | AMY1A (0.77) | AMY1APIM1CD38MAPK8MEN1 | |
| SCHEMBL26255803 | 0.87 | AMY1A (0.77) | AMY1APIM1CD38MAPK8MEN1 | |
| SCHEMBL12557418 | 0.87 | AMY1A (0.77) | AMY1APIM1CD38MAPK8MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1053 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137745-A1 | QUERCETAGETIN ENRICHED MARIGOLD EXTRACTS, COMPOSITIONS, METHODS OF PREPARATION AND USE THEREOF | AVT NATURAL PRODUCTS LTD (IN) | 2026-05-21 | — | — | US | claimed |
| EP-4698662-A2 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-12514266-B2 | Composition containing quercetagetin | CHENGUANG BIOTECH GROUP CO., LTD. (CN) | 2026-01-06 | — | — | US | claimed |
| WO-2025217103-A1 | DURABLE ION EXCHANGE MEMBRANES WITH ADDITIVES | W. L. GORE & ASSOCIATES, INC. (US) | 2025-10-16 | — | — | WO | claimed |
| US-20250302727-A1 | COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES | LABORATOIRES M&L (FR) | 2025-10-02 | — | — | US | claimed |
| US-20250257032-A1 | METHOD OF PREPARING HIGH PURITY LUTEIN ESTER CRYSTALS, AND APPLICATIONS THEREOF | AVT NATURAL PRODUCTS LTD. (IN) | 2025-08-14 | — | — | US | claimed |
| US-20250257331-A1 | FLAVONOID GLYCOSIDE GLYCOSYLTRANSFERASE LbUGT71BX1 IN LAPORTEA BULBIFERA AS WELL AS THE CODING GENE AND THE USE THEREOF | INST CHINESE MATERIA MEDICA CHINA ACADEMY OF CMS (CN) | 2025-08-14 | — | — | US | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120195403-A | Screening method of targeted CD276 small molecule inhibitor and anti-tumor application thereof | 郑州大学 | 2025-06-24 | — | — | CN | claimed |
| WO-2024220449-A9 | REGULATABLE CONTROLLED EXPRESSION OF A TRANSGENE IN PRIMATES | AskBio Inc. (US) | 2025-04-03 | — | — | WO | claimed |
| US-6159585-A | Security paper | GEORGIA-PACIFIC CORPORATION (US) | 2000-12-12 | — | — | US | claimed |
| WO-1998041688-A1 | SECURITY PAPER | GEORGIA-PACIFIC CORPORATION, INC. (US) | 1998-09-24 | — | — | WO | claimed |
| US-5650433-A | REDUCING ARTICULAR CARTILAGE DESTRUCTION IN A PATIENT BY ADMINISTERING A FLAVONOID COMPOUND | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-07-22 | — | — | US | claimed |
| EP-0633022-B1 | Chondroprotective flavones | KUREHA CHEMICAL IND CO LTD (JP) | 1997-02-19 | — | — | EP | claimed |
| EP-0633022-A2 | Chondroprotective flavones | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-11 | — | — | EP | claimed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | claimed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | claimed |
| US-4774229-A | ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-09-27 | — | — | US | claimed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | claimed |
| WO-1987006833-A1 | MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE | CHEMEX PHARMACEUTICALS, INC. (US) | 1987-11-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302727-A1 | COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES | CUTA, IMMT, SYMPK | AMY1A 2724/4885PIM1 2510/4885CD38 4513/4885 |
| US-20260137745-A1 | QUERCETAGETIN ENRICHED MARIGOLD EXTRACTS, COMPOSITIONS, METHODS OF PREPARATION AND USE THEREOF | LIPA, LIPC, CUTA | AMY1A 50/4885PIM1 3311/4885CD38 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.